1. Home
  2. SBI vs ANIX Comparison

SBI vs ANIX Comparison

Compare SBI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBI
  • ANIX
  • Stock Information
  • Founded
  • SBI 1992
  • ANIX 1982
  • Country
  • SBI United States
  • ANIX United States
  • Employees
  • SBI N/A
  • ANIX N/A
  • Industry
  • SBI Finance/Investors Services
  • ANIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBI Finance
  • ANIX Health Care
  • Exchange
  • SBI Nasdaq
  • ANIX Nasdaq
  • Market Cap
  • SBI 104.9M
  • ANIX 88.9M
  • IPO Year
  • SBI N/A
  • ANIX 1987
  • Fundamental
  • Price
  • SBI $7.49
  • ANIX $3.26
  • Analyst Decision
  • SBI
  • ANIX Strong Buy
  • Analyst Count
  • SBI 0
  • ANIX 3
  • Target Price
  • SBI N/A
  • ANIX $9.00
  • AVG Volume (30 Days)
  • SBI 39.5K
  • ANIX 254.0K
  • Earning Date
  • SBI 01-01-0001
  • ANIX 05-28-2025
  • Dividend Yield
  • SBI 4.52%
  • ANIX N/A
  • EPS Growth
  • SBI N/A
  • ANIX N/A
  • EPS
  • SBI N/A
  • ANIX N/A
  • Revenue
  • SBI N/A
  • ANIX N/A
  • Revenue This Year
  • SBI N/A
  • ANIX N/A
  • Revenue Next Year
  • SBI N/A
  • ANIX N/A
  • P/E Ratio
  • SBI N/A
  • ANIX N/A
  • Revenue Growth
  • SBI N/A
  • ANIX N/A
  • 52 Week Low
  • SBI $6.96
  • ANIX $2.07
  • 52 Week High
  • SBI $8.00
  • ANIX $4.20
  • Technical
  • Relative Strength Index (RSI)
  • SBI 46.97
  • ANIX 51.51
  • Support Level
  • SBI $7.40
  • ANIX $3.15
  • Resistance Level
  • SBI $7.49
  • ANIX $3.52
  • Average True Range (ATR)
  • SBI 0.05
  • ANIX 0.26
  • MACD
  • SBI 0.00
  • ANIX -0.03
  • Stochastic Oscillator
  • SBI 53.85
  • ANIX 10.77

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: